1. Home
  2. ZIONO vs NAMSW Comparison

ZIONO vs NAMSW Comparison

Compare ZIONO & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZIONO
  • NAMSW
  • Stock Information
  • Founded
  • ZIONO N/A
  • NAMSW N/A
  • Country
  • ZIONO United States
  • NAMSW Netherlands
  • Employees
  • ZIONO 9679
  • NAMSW 29
  • Industry
  • ZIONO Major Banks
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZIONO Finance
  • NAMSW Health Care
  • Exchange
  • ZIONO Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • ZIONO N/A
  • NAMSW N/A
  • IPO Year
  • ZIONO N/A
  • NAMSW N/A
  • Fundamental
  • Price
  • ZIONO $25.57
  • NAMSW $9.00
  • Analyst Decision
  • ZIONO
  • NAMSW
  • Analyst Count
  • ZIONO 0
  • NAMSW 0
  • Target Price
  • ZIONO N/A
  • NAMSW N/A
  • AVG Volume (30 Days)
  • ZIONO N/A
  • NAMSW N/A
  • Earning Date
  • ZIONO N/A
  • NAMSW N/A
  • Dividend Yield
  • ZIONO N/A
  • NAMSW N/A
  • EPS Growth
  • ZIONO N/A
  • NAMSW N/A
  • EPS
  • ZIONO N/A
  • NAMSW N/A
  • Revenue
  • ZIONO N/A
  • NAMSW N/A
  • Revenue This Year
  • ZIONO N/A
  • NAMSW N/A
  • Revenue Next Year
  • ZIONO N/A
  • NAMSW N/A
  • P/E Ratio
  • ZIONO N/A
  • NAMSW N/A
  • Revenue Growth
  • ZIONO N/A
  • NAMSW N/A
  • 52 Week Low
  • ZIONO N/A
  • NAMSW N/A
  • 52 Week High
  • ZIONO N/A
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ZIONO 56.07
  • NAMSW 47.49
  • Support Level
  • ZIONO $25.45
  • NAMSW $9.40
  • Resistance Level
  • ZIONO $25.55
  • NAMSW $10.14
  • Average True Range (ATR)
  • ZIONO 0.08
  • NAMSW 0.44
  • MACD
  • ZIONO 0.03
  • NAMSW -0.12
  • Stochastic Oscillator
  • ZIONO 93.75
  • NAMSW 24.31

About ZIONO Zions Bancorporation N.A. Dep Shs Repstg 1/40th Perp Pfd Ser G

Zions Bancorporation is a regional U.S. bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: